- Send to a friend
- RSS
- google +
- Print version
- E-mail this page
News (Patient Safety)
The Health-EU news and events feeds are automatically generated following criteria provided by the European Commission. They may contain classification errors.
European Medicines Agency issues six key recommendations to tackle the issue of medication errors» europa.eu
The European Medicines Agency (EMA) has issued six key recommendations to tackle the issue of medication errors causing harm in the European Union (EU).[...]UNFPA - UNFPA Drives Family Planning Innovation to Reach World’s Most Marginalized, at Major Women’s Health Conference » unfpa.org
UNITED NATIONS, New York —UNFPA, the United Nations Population Fund, will launch two new initiatives that will increase access to family planning and improve maternal health in some of the most-hard-[...]Benefits of Diane 35 and generics outweigh risks in specific patient group » europa.eu
The European Medicines Agency?s Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that the benefits of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35 micrograms) and its gener[...]Infographic: Europe’s fight against antimicrobial resistance» europa.eu
Published on: 16 May 2013 The third joint EFSA and ECDC report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods shows the continued presence of resistance to a ran[...]Joint EFSA and ECDC report: resistant bacteria remain an important issue that can affect humans through animals and food.» europa.eu
EFSA is the EU risk assessment body for food and feed safety. It provides independent scientific advice to risk managers.[...]Antimicrobial resistance continues to be found in Salmonella and Campylobacter» europa.eu
Antimicrobial resistance continues to be found in Salmonella and Campylobacter, the latest joint report from the European Food Safety Authority and the European Centre for Disease Prevention and Con[...]Joint EFSA and ECDC report: resistant bacteria remain an important issue that can affect humans through animals and food.» europa.eu
Published on: 16 May 2013 The third joint EFSA and ECDC report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods shows the continued presence of resistance to a ran[...]European Patients' Rights Day: 10 benefits the EU brings to patients» europa.eu
Commission MEMO Brussels, 15 May 2013 European A high level of health protection; the right to benefit from medical treatment; access to healthcare - preventive, diagnostic and curative treatment reg[...]
Periodic Report Summary - CANCERALIA (Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours)»
europa.eu
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III Project context and objectives: Lung and pancreatic cancer represent major public health challenges in Europe and the western world[...]ESC recommends patients and centres for renal denervation » escardio.org
Novel treatment has potential in multiple cardiovascular diseases: Up to 10 percent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascula[...]In the fight against alcohol misuse, pricing policies are the way to go» eurocare.org
Today Members of the European Parliament from various political groups, along with representatives of governments, leading academics and public health organisations, have renewed their support for st[...]In the fight against alcohol misuse, pricing policies are the way to go» epha.org
Today Members of the European Parliament (MEPs) from various political groups, along with representatives of governments, leading academics and public health organisations (1), have renewed their sup[...]European Medicines Agency publishes report on patient recruitment and geographical location of clinical trials» europa.eu
Almost 62% of the patients in pivotal trials submitted in marketing-authorisation applications (MAAs) to the European Medicines Agency between January 2005 and December 2011 were recruited outside of[...]Integrating cardiovascular imaging modalities revolutionises care offered to patients » escardio.org
How the different advanced cardio vascular imaging technologies fit together in managing cardiac patients, will be one of the main themes explored at the International Conference on Nuclear Cardiolog[...]ECDC publishes core competencies for infection control and hospital hygiene professionals in the European Union» europa.eu
With this technical report, the intent of ECDC is to propose a comprehensive list of core competencies that should be adopted by infection control and hospital hygiene professionals across Europe. 26[...]European Medicines Agency Workshop on Medication Errors» epha.org
The European Medicines Agency (EMA) organised a workshop on Medication Errors on 28 February - 1 March, a timely event given that such incidents are much more frequent across Europe than is commonly [...]EU Parliament votes to adopt Antimicrobial Resistance (AMR) measure as part of agricultural reform» epha.org
The European Parliament voted on its plenary session on 13 March on the reform of the Common Agricultural Policy (CAP). As part of this vote, an amendment concerning Antimicrobial Resistance (AMR) wa[...]Informing relatives of heart or lung transplantation patients» escardio.org
The results of this qualitative study showed a gap between the information and support that relatives to newly listed heart or lung transplant patients need and receive. The professional teams and so[...]Pharmaceuticals: New symbol to identify medicines undergoing additional monitoring»
The symbol will allow patients and health care professionals to easily identify medicinal products that are undergoing additional monitoring, and its accompanying text will encourage them to report unexpected adverse reactions through national reporting systems.
Tackling medication errors: European Medicines Agency workshop calls for coordinated EU approach» europa.eu
A close collaboration between national patient safety authorities, national competent authorities, the European Medicines Agency, and the European Commission is necessary to tackle the issue of medic[...]Muscle, skin and gastrointestinal problems cause a quarter of patients with heart disease and strokes to stop treatment in HPS2-THRIVE trial » escardio.org
The largest randomised study of the vitamin niacin in patients with occlusive arterial disease (narrowing of the arteries) has shown a significant increase in adverse side-effects when it is combined[...]Family plays an important role in promoting fruit and vegetable eating particularly where free school lunch is not provided» eufic.org
Children from families that encourage fruit and vegetable consumption are more likely to report eating fruits and vegetables each day. This association was most apparent for vegetable intakes in coun[...]AGE report on the conclusions and recommendations of the DREAMING Advisory Board on the acceptance, added value and challenges of telemonitoring »
The DREAMING project, which carried out randomised control trials across six pilot sites to assess the impact of telemonitoring on the health and quality of life of older people with chronic conditions, concluded its activities in June 2012.